menu
    • menu

    Company profile for BryoLogyx Inc

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies. The company is capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the immune response unleashed by cancer immunotherapy; and the invention of the first practical synthetic production method for bryo...
    BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies. The company is capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the immune response unleashed by cancer immunotherapy; and the invention of the first practical synthetic production method for bryostatin and analogs, enabling their availability for commercial development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BryoLogyx IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2485 Holly Oak Drive Danville, CA 94506
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bryologyx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BryoLogyx Announces Additions to Board of Directors and Scientific
    BryoLogyx Announces Additions to Board of Directors and Scientific

    21 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211221005042/en/BryoLogyx-Announces-Additions-to-Board-of-Directors-and-Scientific-and-Medical-Advisory-Board

    BUSINESSWIRE
    21 Dec 2021
    Share Share
    BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1
    BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1

    12 Oct 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201013005116/en

    BUSINESSWIRE
    12 Oct 2020
    Share Share
    BryoLogyx Announces Cooperative R&D Agreement for Bryostatin-1
    BryoLogyx Announces Cooperative R&D Agreement for Bryostatin-1

    04 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200804005180/en

    BUSINESSWIRE
    04 Aug 2020
    Share Share
    BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1 Synthesized by AMRI
    BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1 Synthesized by AMRI

    12 Jun 2020

    // PRESS RELEASE

    https://www.amriglobal.com/blog/news-and-events/news/bryologyx-announces-agreements-with-neurotrope-to-acquire-bryostatin-1-immuno-oncology-data-package-supply-synthetic-bryostatin-1-synthesized-by-amri/

    PRESS RELEASE
    12 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search